^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    TP53 mutation + TTN mutation

    i
    Other names: TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1, TTN, Titin, Rhabdomyosarcoma Antigen MU-RMS-40.14, Connectin, Cardiomyopathy Dilated 1G (Autosomal Dominant), LGMDR10, LGMD2J, CMPD4, EOMFC, HMERF, MYLK5, SALMY, CMD1G, CMH9, TMD
    Entrez ID:
    7157; 7273
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    1year
    Genomic and immune landscape in hepatocellular carcinoma: Implications for personalized therapeutics. (PubMed, Environ Toxicol)
    Further, ATP6V1G1 was recognized in its role in apoptosis and migration in HCC cells. In conclusion, our findings illuminate the complexities of HCC progression, potential predictive genetic markers for drug response, and the pivotal role of ATP6V1G1, suggesting avenues for targeted therapeutic strategies in HCC.
    Journal
    |
    TP53 (Tumor protein P53) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • TTN (Titin)
    |
    TP53 mutation • TTN mutation • TP53 mutation + TTN mutation